{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:49:26Z","timestamp":1791748166737,"version":"4.3.4"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fund for Scientific Research","doi-asserted-by":"publisher","award":["AMG-Onco P.A002.23"],"award-info":[{"award-number":["AMG-Onco P.A002.23"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006673","name":"Fonds L\u00e9on Fredericq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005627","name":"Universit\u00e9 de Li\u00e8ge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005627","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.molmed.2026.09.009","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:34:20Z","timestamp":1791635660000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting outcomes in oncogenic HPV infection: are we there yet?"],"prefix":"10.1016","author":[{"given":"Diane","family":"Bruyere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romane","family":"Geuzaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4382-8997","authenticated-orcid":false,"given":"Michael","family":"Herfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2026.09.009_bb0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41579-021-00617-5","article-title":"Human papillomaviruses: diversity, infection and host interactions","volume":"20","author":"McBride","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0010","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjose","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.molmed.2026.09.009_bb0015","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/infdis\/jiv753","article-title":"Natural acquired immunity against subsequent genital human papillomavirus infection: a systematic review and meta-analysis","volume":"213","author":"Beachler","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molmed.2026.09.009_bb0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13027-023-00546-3","article-title":"Association of naturally acquired type-specific HPV antibodies and subsequent HPV re-detection: systematic review and meta-analysis","volume":"18","author":"Yokoji","year":"2023","journal-title":"Infect. Agent. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0030","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0035","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1186\/s12879-025-12137-1","article-title":"Human papilloma virus genotypes associated with non-cervical HPV positive cancer development in UK and Ireland cohorts: a systematic review","volume":"25","author":"Mallon","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.molmed.2026.09.009_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29190","article-title":"Prevalence and genotype distribution of human papillomavirus in cervical adenocarcinoma (usual type and variants): a systematic review and meta-analysis","volume":"95","author":"Reynders","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100853","article-title":"Human papillomavirus infection is a favorable prognostic factor for patients with stages I to IVA esophageal squamous cell carcinoma but not adenocarcinoma","volume":"38","author":"Reynders","year":"2025","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0050","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/PAS.0000000000002235","article-title":"Transcriptionally active human papillomavirus infection in a minority of esophageal squamous cell carcinomas in North America","volume":"48","author":"Bauer","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/v15020451","article-title":"The prevalence of HPV in oral cavity squamous cell carcinoma","volume":"15","author":"Katirachi","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.molmed.2026.09.009_bb0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1158\/2159-8290.CD-22-0489","article-title":"Human papillomavirus 42 drives digital papillary adenocarcinoma and elicits a germ cell-like program conserved in HPV-positive cancers","volume":"13","author":"Leiendecker","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.molmed.2026.09.009_bb0065","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41416-018-0049-2","article-title":"A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine","volume":"118","author":"Herfs","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0070","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.molmed.2026.09.009_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01178-25","article-title":"A comprehensive reference catalog of human skin DNA virome reveals novel viral diversity and microenvironmental influences","volume":"13","author":"Li","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.molmed.2026.09.009_bb0080","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/jid.2011.91","article-title":"Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma","volume":"131","author":"Arron","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002807","article-title":"HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage","volume":"8","author":"Wallace","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2026.09.009_bb0090","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1128\/JVI.06579-11","article-title":"Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types","volume":"86","author":"Cornet","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0095","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1158\/0008-5472.CAN-04-3263","article-title":"Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8","volume":"65","author":"Schaper","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2026.09.009_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002125","article-title":"E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice","volume":"7","author":"Viarisio","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2026.09.009_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006723","article-title":"The interplay of UV and cutaneous papillomavirus infection in skin cancer development","volume":"13","author":"Hasche","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2026.09.009_bb0110","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJMc2213180","article-title":"CXCR4 antagonist in HPV5-associated perianal squamous-cell carcinoma","volume":"390","author":"Marin-Esteban","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2026.09.009_bb0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMoa2502114","article-title":"Resolution of squamous-cell carcinoma by restoring T-cell receptor signaling","volume":"393","author":"Ye","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2026.09.009_bb0120","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.jid.2026.02.011","article-title":"Pathophysiology of cutaneous commensal human papillomaviruses","volume":"146","author":"Bruyere","year":"2026","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccell.2024.11.013","article-title":"Commensal papillomavirus immunity preserves the homeostasis of highly mutated normal skin","volume":"43","author":"Son","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2026.09.009_bb0130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41586-019-1719-9","article-title":"Immunity to commensal papillomaviruses protects against skin cancer","volume":"575","author":"Strickley","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.09.009_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2026.101401","article-title":"Exceeding expectations: factors contributing to the potency of human papillomavirus vaccines","volume":"7","author":"Schiller","year":"2026","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.molmed.2026.09.009_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.909223","article-title":"Prophylactic and therapeutic HPV vaccines: current scenario and perspectives","volume":"12","author":"Mo","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100836","article-title":"Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis","volume":"34","author":"Dorji","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.molmed.2026.09.009_bb0150","article-title":"Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review","volume":"13","author":"Hamid","year":"2025","journal-title":"Ther. Adv. Vaccines Immunother."},{"key":"10.1016\/j.molmed.2026.09.009_bb0155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fmicb.2012.00152","article-title":"Productive lifecycle of human papillomaviruses that depends upon squamous epithelial differentiation","volume":"3","author":"Kajitani","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PGP.0b013e31826916c7","article-title":"The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"32","author":"Darragh","year":"2013","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0165","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.humpath.2013.10.014","article-title":"The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3","volume":"45","author":"Litjens","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0170","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/sj.bjc.6601726","article-title":"Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions","volume":"90","author":"Clavel","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0175","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199210293271804","article-title":"A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection","volume":"327","author":"Koutsky","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2026.09.009_bb0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/PGP.0000000000000311","article-title":"Thin HSIL of the cervix: detecting a variant of high-grade squamous intraepithelial lesions with a p16INK4a antibody","volume":"36","author":"Reich","year":"2017","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0185","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/PAS.0000000000000318","article-title":"Two major pathways for development of high-grade squamous intraepithelial lesions of the cervix","volume":"38","author":"Reich","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2024.102108","article-title":"Copy number profiling implicates thin high-grade squamous intraepithelial lesions as a true precursor of cervical human papillomavirus-induced squamous cell cancer","volume":"104","author":"Reich","year":"2024","journal-title":"Lab. Invest."},{"key":"10.1016\/j.molmed.2026.09.009_bb0195","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/his.13869","article-title":"Thin variant of high-grade squamous intraepithelial lesion - relationship with high-risk and possibly carcinogenic human papilloma virus subtypes and somatic cancer gene mutations","volume":"75","author":"Regauer","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.molmed.2026.09.009_bb0200","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/jcp.2003.008656","article-title":"HPV infections and tonsillar carcinoma","volume":"57","author":"Syrjanen","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0205","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1002\/cam4.2450","article-title":"Differences in gene expression between high-grade dysplasia and invasive HPV(+) and HPV(-) tonsillar and base of tongue cancer","volume":"8","author":"Haeggblom","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.molmed.2026.09.009_bb0210","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41388-023-02927-9","article-title":"HPV-associated oropharyngeal cancer: in search of surrogate biomarkers for early lesions","volume":"43","author":"Lim","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2026.09.009_bb0215","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/ijc.70207","article-title":"Spatial evidence for carcinoma in situ (CIS) as an entity in human papillomavirus (HPV)-associated tonsillar squamous cell carcinoma (TSCC)","volume":"158","author":"Nasman","year":"2026","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0220","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.3390\/ijms23094943","article-title":"HPV16 and HPV18 genome structure, expression, and post-transcriptional regulation","volume":"23","author":"Yu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2026.09.009_bb0225","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41392-024-02083-w","article-title":"Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.molmed.2026.09.009_bb0230","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001540","article-title":"The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation","volume":"102","author":"Scarth","year":"2021","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0235","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw100","article-title":"HPV16 sublineage associations with histology-specific cancer risk using HPV whole-genome sequences in 3200 women","volume":"108","author":"Mirabello","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.molmed.2026.09.009_bb0240","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0245","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01875-21","article-title":"High-risk mucosal human papillomavirus 16 (HPV16) E6 protein and cutaneous HPV5 and HPV8 E6 proteins employ distinct strategies to interfere with interferon regulatory factor 3-mediated beta interferon expression","volume":"96","author":"Poirson","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0250","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1172\/JCI129497","article-title":"HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING","volume":"130","author":"Luo","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2026.09.009_bb0255","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ijc.34128","article-title":"Different human papillomavirus types share early natural history transitions in immunocompetent women","volume":"151","author":"Adebamowo","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0260","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1128\/JCM.00783-10","article-title":"Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV study","volume":"48","author":"Louvanto","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126841","article-title":"Human papillomavirus type 16 and 18 viral clearance and progression to precancer among women aged 18-25 years enrolled in the Costa Rica HPV prophylactic vaccine trial (CVT)","volume":"50","author":"Sierra","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.molmed.2026.09.009_bb0270","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/cid\/ciy738","article-title":"Incidence and clearance of anal high-risk human papillomavirus infections and their determinants over 5 years among human immunodeficiency virus-negative men who have sex with men","volume":"68","author":"Marra","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2026.09.009_bb0275","doi-asserted-by":"crossref","first-page":"10516","DOI":"10.1073\/pnas.1202684109","article-title":"A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer","volume":"109","author":"Herfs","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2026.09.009_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2025.104166","article-title":"Role of reserve cells in metaplasia and the development of human papillomavirus-associated high-grade squamous intraepithelial lesions at the cervical transformation zone","volume":"105","author":"Aiyenuro","year":"2025","journal-title":"Lab. Invest."},{"key":"10.1016\/j.molmed.2026.09.009_bb0285","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1470-2045(24)00189-X","article-title":"Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis","volume":"25","author":"Jin","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0290","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41431-023-01521-7","article-title":"Genome, HLA and polygenic risk score analyses for prevalent and persistent cervical human papillomavirus (HPV) infections","volume":"32","author":"Adebamowo","year":"2024","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2026.09.009_bb0295","doi-asserted-by":"crossref","first-page":"12450","DOI":"10.1128\/JVI.77.23.12450-12459.2003","article-title":"Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection","volume":"77","author":"Kim","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0300","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2008.10.012","article-title":"Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science","volume":"112","author":"Wentzensen","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0305","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.immuni.2015.04.019","article-title":"Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract","volume":"42","author":"Anahtar","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2026.09.009_bb0310","doi-asserted-by":"crossref","first-page":"E762","DOI":"10.1073\/pnas.1518589113","article-title":"Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa","volume":"113","author":"Oh","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2026.09.009_bb0315","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/s41467-020-15856-y","article-title":"The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions","volume":"11","author":"Mitra","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.09.009_bb0320","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s41467-022-28724-8","article-title":"HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources","volume":"13","author":"Lebeau","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.09.009_bb0325","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/infdis\/jiy497","article-title":"The burden of human papillomavirus and Chlamydia trachomatis coinfection in women: a large cohort study in Inner Mongolia, China","volume":"219","author":"Ji","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molmed.2026.09.009_bb0330","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00038-019-01261-w","article-title":"Association between human papillomavirus and Chlamydia trachomatis infection risk in women: a systematic review and meta-analysis","volume":"64","author":"Naldini","year":"2019","journal-title":"Int. J. Public Health"},{"key":"10.1016\/j.molmed.2026.09.009_bb0335","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1093\/infdis\/jiaf033","article-title":"Association between herpes simplex virus type 2 and high-risk human papillomavirus infections: a population study of the National Health and Nutrition Examination Survey, 2009-2016","volume":"231","author":"Liu","year":"2025","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molmed.2026.09.009_bb0340","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2026.09.009_bb0345","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","article-title":"Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study","volume":"359","author":"Moreno","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2026.09.009_bb0350","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/infdis\/jir560","article-title":"Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand","volume":"204","author":"Marks","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molmed.2026.09.009_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.102650","article-title":"Long-term oral contraceptive use as a risk factor for high-grade cervical lesions in women with high-risk human papillomavirus: a retrospective cohort analysis","volume":"35","author":"Farzaneh","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0360","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1073\/pnas.93.7.2930","article-title":"Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice","volume":"93","author":"Arbeit","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2026.09.009_bb0365","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/carcin\/bgt350","article-title":"Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice","volume":"35","author":"Son","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.molmed.2026.09.009_bb0370","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/pathogens9050403","article-title":"The relationship between estrogen-related signaling and human papillomavirus positive cancers","volume":"9","author":"James","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.molmed.2026.09.009_bb0375","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ijc.21493","article-title":"Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies","volume":"118","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0380","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/jnci\/89.12.868","article-title":"Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers","volume":"89","author":"Prokopczyk","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.molmed.2026.09.009_bb0385","first-page":"34","article-title":"Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study","volume":"39","author":"Poppe","year":"1995","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.molmed.2026.09.009_bb0390","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12985-025-02904-6","article-title":"Multiple high-risk human papillomavirus infections exacerbate cervical lesion risk: epidemiological evidence from suining, Sichuan","volume":"22","author":"Jing","year":"2025","journal-title":"Virol. J."},{"key":"10.1016\/j.molmed.2026.09.009_bb0395","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1128\/JCM.00087-13","article-title":"Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities","volume":"51","author":"Schmitt","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0400","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3390\/v13071342","article-title":"Multiple human papilloma virus (HPV) infections are associated with HSIL and persistent HPV infection status in Korean patients","volume":"13","author":"Kim","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.molmed.2026.09.009_bb0405","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/aogs.12835","article-title":"Spontaneous regression of CIN2 in women aged 18-24 years: a retrospective study of a state-wide population in Western Australia","volume":"95","author":"Munro","year":"2016","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.molmed.2026.09.009_bb0410","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1038\/s41598-018-24882-2","article-title":"Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis","volume":"8","author":"Bekos","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2026.09.009_bb0415","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(02)08151-5","article-title":"Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study","volume":"359","author":"Munoz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2026.09.009_bb0420","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/bjc.2012.513","article-title":"Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up","volume":"108","author":"Jensen","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0425","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-088753","article-title":"Socioeconomic inequality in cervical cancer screening uptake among women in sub-Saharan Africa: a decomposition analysis of Demographic and Health Survey data","volume":"14","author":"Asgedom","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.molmed.2026.09.009_bb0430","doi-asserted-by":"crossref","first-page":"F24","DOI":"10.1016\/j.vaccine.2012.05.089","article-title":"Updating the natural history of human papillomavirus and anogenital cancers","volume":"30","author":"Moscicki","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.molmed.2026.09.009_bb0435","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/AOG.0000000000006257","article-title":"Screening for cervical cancer","volume":"148","author":"American College of Obstetricians & Gynecologists\u2019 Committee on Clinical Consensus\u2013Gynecology","year":"2026","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0440","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1158\/1055-9965.EPI-22-0054","article-title":"Extended human papillomavirus genotyping to predict progression to high-grade cervical precancer: a prospective cohort study in the Southeastern United States","volume":"31","author":"Bukowski","year":"2022","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.molmed.2026.09.009_bb0445","doi-asserted-by":"crossref","first-page":"655.e1","DOI":"10.1016\/j.ajog.2024.01.029","article-title":"Human papillomavirus genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2","volume":"230","author":"Damgaard","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0450","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3390\/diagnostics11091634","article-title":"Usefulness of E7 mRNA in HPV16-positive women to predict the risk of progression to HSIL\/CIN2","volume":"11","author":"Marti","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.molmed.2026.09.009_bb0455","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12985-022-01822-1","article-title":"Possible role of negative human papillomavirus E6\/E7 mRNA as a predictor of regression of cervical intraepithelial neoplasia 2 lesions in hr-HPV positive women","volume":"19","author":"Bruno","year":"2022","journal-title":"Virol. J."},{"key":"10.1016\/j.molmed.2026.09.009_bb0460","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/jnci\/djaa105","article-title":"p16\/ki67 and E6\/E7 mRNA accuracy and prognostic value in triaging HPV DNA-positive women","volume":"113","author":"Rossi","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.molmed.2026.09.009_bb0465","first-page":"153","article-title":"Evaluating HPV viral load and multiple infections for enhanced cervical cancer risk-based assessment","volume":"15","author":"Varesano","year":"2025","journal-title":"Life (Basel)"},{"key":"10.1016\/j.molmed.2026.09.009_bb0470","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/infdis\/jir049","article-title":"Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study","volume":"203","author":"Xi","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molmed.2026.09.009_bb0475","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/1471-0528.17597","article-title":"Testing for viral DNA integration among HPV-positive women to detect cervical precancer: an observational cohort study","volume":"131","author":"Hu","year":"2024","journal-title":"BJOG"},{"key":"10.1016\/j.molmed.2026.09.009_bb0480","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/IGC.0b013e3182a80b14","article-title":"Follow-up study of patients with cervical intraepithelial neoplasia grade 1 overexpressing p16Ink4a","volume":"23","author":"Cortecchia","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0485","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/PGP.0000000000000326","article-title":"HPV L1 and P16 expression in CIN1 to predict future CIN2","volume":"36","author":"Liu","year":"2017","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0490","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.31557\/APJCP.2019.20.6.1809","article-title":"Progression of precancerous cervical lesion predicted by p16 protein immunohistochemistry in Rajavithi Hospital","volume":"20","author":"Charoonwatana","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.molmed.2026.09.009_bb0495","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/modpathol.2010.109","article-title":"Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression","volume":"23","author":"Ovestad","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0500","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0002-9440(10)62341-3","article-title":"Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer","volume":"166","author":"Heselmeyer-Haddad","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0505","first-page":"289","article-title":"Prospective study of hTERC gene detection by fluorescence in situ hybridization (FISH) in cervical intraepithelial neoplasia 1 natural prognosis","volume":"35","author":"Li","year":"2014","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0510","first-page":"1599","article-title":"Gain of human telomerase RNA gene is associated with progression of cervical intraepithelial neoplasia grade I or II","volume":"125","author":"Lan","year":"2012","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.molmed.2026.09.009_bb0515","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1186\/s12885-023-11518-6","article-title":"Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States","volume":"23","author":"Bukowski","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0520","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ijc.31539","article-title":"Cervical cancer risk in HPV-positive women after a negative FAM19A4\/mir124-2 methylation test: a post hoc analysis in the POBASCAM trial with 14 year follow-up","volume":"143","author":"De Strooper","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0525","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.3390\/ijms24076479","article-title":"The role of methylation of host and\/or human papillomavirus (HPV) DNA in management of cervical intraepithelial neoplasia grade 2 (CIN2) lesions","volume":"24","author":"Dovnik","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2026.09.009_bb0530","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.3390\/cancers17193095","article-title":"The DNA methylation marker ZNF671 has prognostic value for progressing cervical intraepithelial neoplasia","volume":"17","author":"Dubbel","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.molmed.2026.09.009_bb0535","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/cid\/ciz677","article-title":"Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia","volume":"70","author":"Louvanto","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2026.09.009_bb0540","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/ijc.27750","article-title":"Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia","volume":"132","author":"Mirabello","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0545","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13073-022-01116-9","article-title":"The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer","volume":"14","author":"Barrett","year":"2022","journal-title":"Genome Med."},{"key":"10.1016\/j.molmed.2026.09.009_bb0550","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.3390\/cancers15153951","article-title":"Evaluation of CIN2\/3 lesion regression in GynTect((R)) DNA methylation-marker-negative patients in a longitudinal study","volume":"15","author":"Hoyer","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.molmed.2026.09.009_bb0555","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13148-020-00963-w","article-title":"Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays","volume":"12","author":"Dippmann","year":"2020","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.molmed.2026.09.009_bb0560","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.70626","article-title":"Triage performance of FAM19A4\/miR124-2 methylation: 18-month follow-up results from a prospective observational study within the Dutch primary HPV-based cervical screening program","author":"Verhoef","year":"2026","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0565","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/PAS.0000000000000747","article-title":"CK7 immunohistochemistry as a predictor of CIN1 progression: a retrospective study of patients from the quadrivalent HPV vaccine trials","volume":"41","author":"Mills","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0570","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/PAS.0000000000000548","article-title":"Predictive value of cytokeratin 7 immunohistochemistry in cervical low-grade squamous intraepithelial lesion as a marker for risk of progression to a high-grade lesion","volume":"40","author":"Paquette","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0575","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000545229","article-title":"The role of cytokeratin 7 and cytokeratin 19 immunohistochemistry in the evaluation of human papillomavirus-induced cervical squamous precursor epithelial lesions","volume":"92","author":"Hinai","year":"2025","journal-title":"Pathobiology"},{"key":"10.1016\/j.molmed.2026.09.009_bb0580","first-page":"4109","article-title":"p16INK4a and Ki-67 measurement predict progression of cervical low-grade squamous intraepithelial lesion","volume":"11","author":"Zhang","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0585","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/s41467-020-14730-1","article-title":"Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance","volume":"11","author":"Zhu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.09.009_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.106024","article-title":"HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas","volume":"11","author":"Filippini","year":"2026","journal-title":"ESMO Open"},{"key":"10.1016\/j.molmed.2026.09.009_bb0595","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-21-0625","article-title":"Circulating HPV DNA as a marker for early detection of relapse in patients with cervical cancer","volume":"27","author":"Jeannot","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2026.09.009_bb0600","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2026.37.e68","article-title":"P16\/Ki67 dual staining versus cytology for identifying high-grade cervical intraepithelial neoplasia (CIN2+\/CIN3+) in triage management of HR-HPV-positive women: a systematic review and meta-analysis","volume":"37","author":"Zhou","year":"2026","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0605","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ebiom.2019.10.053","article-title":"The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: a systematic review and meta-analysis","volume":"50","author":"Bowden","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.molmed.2026.09.009_bb0610","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.3390\/ijms20092262","article-title":"CADM1, MAL, and miR124 promoter methylation as biomarkers of transforming cervical intrapithelial lesions","volume":"20","author":"Pino","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2026.09.009_bb0615","first-page":"131","article-title":"Gene promoter methylation patterns throughout the process of cervical carcinogenesis","volume":"32","author":"Yang","year":"2010","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0620","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5468\/ogs.25041","article-title":"Recent advances in applications of machine learning in cervical cancer research: a focus on prediction models","volume":"68","author":"Abrar","year":"2025","journal-title":"Obstet. Gynecol. Sci."},{"key":"10.1016\/j.molmed.2026.09.009_bb0625","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/vaccines10040579","article-title":"Development of a nomogram predicting the risk of persistence\/recurrence of cervical dysplasia","volume":"10","author":"Bogani","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.molmed.2026.09.009_bb0630","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1186\/s12885-026-16263-0","article-title":"External validation of predictive models for high-grade cervical lesions in Thai women undergoing colposcopy: a retrospective external validation study","volume":"26","author":"Eidbur","year":"2026","journal-title":"BMC Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2026.1786335","article-title":"Risk-stratified surveillance after LEEP: a nomogram integrating HPV persistence, margin status, and clinical factors to predict CIN2+ recurrence","volume":"16","author":"Shang","year":"2026","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0640","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12885-023-10646-3","article-title":"Developing a predictive nomogram for colposcopists: a retrospective, multicenter study of cervical precancer identification in China","volume":"23","author":"Xue","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0645","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12880-023-01059-6","article-title":"Prediction of lymph node status in patients with early-stage cervical cancer based on radiomic features of magnetic resonance imaging (MRI) images","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Med. Imaging"},{"key":"10.1016\/j.molmed.2026.09.009_bb0650","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.brachy.2022.06.007","article-title":"Brachytherapy outcome modeling in cervical cancer patients: a predictive machine learning study on patient-specific clinical, physical and dosimetric parameters","volume":"21","author":"Abdalvand","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.molmed.2026.09.009_bb0655","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2013.52.3464","article-title":"Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal","volume":"32","author":"Serup-Hansen","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0660","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(23)00013-X","article-title":"Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis","volume":"24","author":"Mehanna","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2026.103819","article-title":"Prediction models for high-grade cervical lesions or worse using machine learning","volume":"93","author":"Deng","year":"2026","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.molmed.2026.09.009_bb0670","article-title":"Development, validation, and clinical application of a machine learning model for risk stratification and management of cervical cancer screening based on full-genotyping hrHPV test (SMART-HPV): a modelling study","volume":"55","author":"Dong","year":"2025","journal-title":"Lancet Reg. Health West. Pac."},{"key":"10.1016\/j.molmed.2026.09.009_bb0675","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.26890","article-title":"Use of virus genotypes in machine learning diagnostic prediction models for cervical cancer in women with high-risk human papillomavirus infection","volume":"6","author":"Xiao","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.molmed.2026.09.009_bb0680","article-title":"A multi-variable predictive warning model for cervical cancer using clinical and SNPs data","volume":"11","author":"Li","year":"2024","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.molmed.2026.09.009_bb0685","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1016\/S2352-3018(19)30434-5","article-title":"Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis","volume":"7","author":"Kelly","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.molmed.2026.09.009_bb0690","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","article-title":"Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis","volume":"18","author":"Lin","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.molmed.2026.09.009_bb0695","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/PPO.0000000000000115","article-title":"Prevalence of human papillomavirus in oropharyngeal cancer: a systematic review","volume":"21","author":"Stein","year":"2015","journal-title":"Cancer J."},{"key":"10.1016\/j.molmed.2026.09.009_bb0700","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/1541-7786.MCR-20-0884","article-title":"Genomic landscape of primary and recurrent anal squamous cell carcinomas in relation to HPV integration, copy-number variation, and DNA damage response genes","volume":"19","author":"Aldersley","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.molmed.2026.09.009_bb0705","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41416-020-01153-4","article-title":"Human papilloma virus (HPV) integration signature in cervical cancer: identification of MACROD2 gene as HPV hot spot integration site","volume":"124","author":"Kamal","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.molmed.2026.09.009_bb0710","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jcv.2013.12.006","article-title":"Mate pair sequencing of oropharyngeal squamous cell carcinomas reveals that HPV integration occurs much less frequently than in cervical cancer","volume":"59","author":"Gao","year":"2014","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0715","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1002\/1878-0261.13219","article-title":"Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma","volume":"16","author":"Mainguene","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.molmed.2026.09.009_bb0720","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149142600225X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149142600225X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:37:46Z","timestamp":1791747466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149142600225X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":144,"alternative-id":["S147149142600225X"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2026.09.009","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting outcomes in oncogenic HPV infection: are we there yet?","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2026.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}